Table 2 Distribution and frequency of the CT pulmonary abnormalities at different phases
|  | Early phase (0–2 days; n = 60) | Intermediate phase (3–7 days; n = 116) | Late phase (8–14 days; n = 36) |
|---|---|---|---|
No CT findings | 32 (15.1%) | 4 (1.9%) | – |
Positive CT findings | 28 (13.2%) | 112 (52.8%) | 36 (17%) |
GGO only | 24 (11.3%) | 9 (4.2%) | – |
Consolidation only | – | 12 (5.7%) | – |
Both | 4 (1.9%) | 57 (26.9%) | 36 (17%) |
Crazy paving | – | 32 (15.1%) | 24 (11.3%) |
Reversed halo | – | 16 (%) | 20 (9.4%) |
Linear consolidation | – | – | 28 (13.2%) |
Pleural effusion | – | 4 (1.9%) | – |
Peripheral distribution | 23 (10.8%) | 24 (11.3%) | 4 (1.9%) |
Central distribution | – | – | – |
Diffuse distribution | 5 (2.3%) | 88 (41.5%) | 32 (15.1%) |
Unilateral lung affection | 4 (1.9%) | – | – |
bilateral lung affection | 24 (11.3%) | 112 (52.8%) | 36 (17%) |
One lobe of affection | 4 (1.9%) | – | – |
Two lobes of affection | 7 (3.3%) | – | – |
Three lobes of affection | 13 (6.1%) | 28 (13.2%) | – |
Four lobes of affection | 4 (1.9%) | 48 (22.6%) | 13 (6.1%) |
Five lobes of affection | – | 35 (16.5%) | 24 (11.3%) |
Total lung severity score mean ± SD | 2.13 ± 2.574 | 16.08 ± 3.141 | 17.83 ± 3.229 |